Biochemical composition and heterogeneity of heparan sulfates isolated from AH-130 ascites hepatoma cells and fluid.
The glycosaminoglycan composition of AH-130 ascites hepatoma cells and fluid were examined using enzymatic digestion, electrophoresis, and sequential partition fractionation. The cell-associated glycosaminoglycans were found to consist of 93% heparan sulfate, with the remainder consisting primarily of chondroitin sulfate. The glycosaminoglycans isolated from the ascitic fluid were found to consist of 58% heparan sulfate, 26% hyaluronic acid and 16% chondroitin sulfate. Dermatan sulfate was not detected in either cells or fluid. The heparan sulfate isolated from AH-130 cells in low-sulfate and highly heterogeneous with respect to biochemical composition. Fractions isolated by partition fractionation varied from 0.14 mol sulfate/mol uronic acid to 0.6 mol sulfate/mol uronic acid. Of the total sulfate 70--80% is N-sulfate in the former and 50% in the latter. Electrophoresis in 0.1 M HCl showed a highly heterogeneous material with mobility between that of hyaluronic acid and beef lung heparan sulfate. The heparan sulfate isolated from the fluid was similar to that isolated from the cells but was, however, somewhat more homogeneous with respect to charge.
D000818:Animals; D001202:Ascitic Fluid / Q000032:analysis / Q000166:cytology*; D006528:Carcinoma, Hepatocellular / Q000032:analysis*; D002417:Cattle; D006025:Glycosaminoglycans / Q000032:analysis*; D006497:Heparan Sulfate / Q000032:analysis*; D006595:Hexosamines / Q000032:analysis; D008099:Liver / Q000032:analysis; D008113:Liver Neoplasms / Q000032:analysis*; D008168:Lung / Q000032:analysis; D008297:Male; D051381:Rats; D013431:Sulfates / Q000032:analysis; D014574:Uronic Acids / Q000032:analysis
D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D006595:Hexosamines; D013431:Sulfates; D014574:Uronic Acids